BCAX (NASDAQ: BCAX) insider sells 9,200 shares via option exercise

Rhea-AI Filing Summary

BCAX insider reported proposed sale of 9,200 common shares by exercise of stock options, listed as to be sold on 03/23/2026 for cash. The filing also lists three reported dispositions in the prior three months: 01/22/2026 1,882 shares, 03/03/2026 13,555 shares, and 03/04/2026 2,963 shares.

Insights

Securities Transactions Analyst

Notice shows an option exercise sale and recent open-market dispositions totaling material share counts.

The filing lists an exercise of stock options for 9,200 common shares scheduled on 03/23/2026 with the method shown as cash. Prior reported transactions total 18,400 shares across 01/22/2026, 03/03/2026, and 03/04/2026.

Cash-flow treatment is shown as Issuer / Cash for the scheduled sale; additional details about pricing, plan status, or whether trades were pursuant to a trading plan are not provided in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	9200	171120.00	54781950	03/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/23/2026	Exercise of stock options	Issuer			9200	03/23/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	01/22/2026	1882	34162.44
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	03/03/2026	13555	246909.75
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	03/04/2026	2963	54061.71

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the BCAX Form 144 report?

The filing reports a proposed sale of 9,200 common shares via exercise of stock options on 03/23/2026. It also lists three prior dispositions totaling 18,400 shares in the past three months.

Who is selling the BCAX shares listed in the Form 144?

The excerpt shows transactions attributed to an individual, Ivan Hyep, for prior sales and lists the scheduled option exercise sale on 03/23/2026. The filing names the reporting party and addresses where provided.

How were the scheduled BCAX shares to be sold?

The item for 03/23/2026 is described as an exercise of stock options with the sale method listed as Cash and the recipient column showing Issuer in the excerpt.

What quantities were sold in the prior three months for BCAX?

The filing lists prior dispositions of 1,882 shares on 01/22/2026, 13,555 shares on 03/03/2026, and 2,963 shares on 03/04/2026, with dollar amounts shown in the excerpt.

Does the Form 144 state the sale prices for BCAX transactions?

The excerpt displays aggregate dollar amounts next to prior sale rows (for example $34,162.44 for 01/22/2026), but detailed per-share pricing for the scheduled 9,200 share exercise on 03/23/2026 is not shown in the provided excerpt.